Live Breaking News & Updates on Quarter For Mirum Pharmaceuticals

Stay updated with breaking news from Quarter for mirum pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Frazier Life Sciences Management L.P. Grows Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […] ....

United States , Stifel Nicolaus , Eric Bjerkholt , Saira Ramasastry , News Ratings For Mirum Pharmaceuticals Daily , Wetzel Investment Advisors Inc , Quest Partners , China Universal Asset Management Co , Stepstone Group , Insider Transactions At Mirum Pharmaceuticals , Quarter For Mirum Pharmaceuticals , Morgan Stanley , Mirum Pharmaceuticals Stock Down , Mirum Pharmaceuticals , Cantor Fitzgerald , Exchange Commission , Frazier Life Sciences Management , Mirum Pharmaceuticals Profile , Mirum Pharmaceuticals Inc , Free Report , Investment Advisors , Stone Group , Universal Asset Management , Director Saira Ramasastry , Pharmaceuticals Stock Down , Get Free Report ,

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Director Sells $128,400.00 in Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) Director Saira Ramasastry sold 5,000 shares of Mirum Pharmaceuticals stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $25.68, for a total value of $128,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […] ....

New York , United States , Saira Ramasastry , Securities Exchange Commission , Quarter For Mirum Pharmaceuticals , Institutional Investors Weigh In On Mirum Pharmaceuticals , Mirum Pharmaceuticals , News Ratings For Mirum Pharmaceuticals Daily , Mirum Pharmaceuticals Trading , Swiss National Bank , York State Common Retirement Fund , Wetzel Investment Advisors Inc , Janney Montgomery Scott , Morgan Stanley , Mirum Pharmaceuticals Inc , Get Free Report , Director Saira Ramasastry , Exchange Commission , National Bank , Montgomery Scott , State Equity Partners , Wetzel Investment Advisors , Investment Advisors , Mirum Pharmaceuticals Daily ,

836,302 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Bought by First Turn Management LLC

836,302 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Bought by First Turn Management LLC
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Stifel Nicolaus , Peter Radovich , Eric Bjerkholt , Mirum Pharmaceuticals Inc , News Ratings For Mirum Pharmaceuticals Daily , Securities Exchange Commission , Cantor Fitzgerald , China Universal Asset Management Co , Mirum Pharmaceuticals , Quarter For Mirum Pharmaceuticals , Wetzel Investment Advisors Inc , First Turn Management , Mirum Pharmaceuticals Company Profile , Mirum Pharmaceuticals Stock Performance , Free Report , Turn Management , Universal Asset Management , Investment Advisors , Retirement System , Arizona State Retirement System , Exchange Commission , Get Free Report , Visit Holdingschannel , Mirum Pharmaceuticals Daily ,

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) COO Peter Radovich Sells 4,303 Shares

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 4,303 shares of Mirum Pharmaceuticals stock in a transaction on Monday, March 25th. The stock was sold at an average price of $25.80, for a total transaction of $111,017.40. Following the sale, the chief operating officer now directly owns 29,013 shares of the […] ....

Los Angeles , United States , Peter Radovich , Raymond James , China Universal Asset Management Co , Institutional Trading Of Mirum Pharmaceuticals , Mirum Pharmaceuticals Price Performance , Mirum Pharmaceuticals Inc , Mirum Pharmaceuticals , Los Angeles Capital Management , Royal Bank , Life Insurance Co , Quarter For Mirum Pharmaceuticals , Cantor Fitzgerald , News Ratings For Mirum Pharmaceuticals Daily , Silverarc Capital Management , Get Free Report , Capital Management , Universal Asset Management , Angeles Capital Management , Mirum Pharmaceuticals Daily ,

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) COO Sells $111,017.40 in Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 4,303 shares of the firm’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $25.80, for a total value of $111,017.40. Following the completion of the transaction, the chief operating officer now owns 29,013 shares […] ....

United States , Peter Radovich , Raymond James , Wetzel Investment Advisors Inc , Life Insurance Co , Royal Bank , Quarter For Mirum Pharmaceuticals , News Ratings For Mirum Pharmaceuticals Daily , Mirum Pharmaceuticals Company Profile , Cantor Fitzgerald , China Universal Asset Management Co , Institutional Trading Of Mirum Pharmaceuticals , Mirum Pharmaceuticals , Mirum Pharmaceuticals Price Performance , Mirum Pharmaceuticals Inc , Get Free Report , Universal Asset Management , Investment Advisors , Mirum Pharmaceuticals Daily ,